yet such cases seldom display overt signs of hemorrhage, 4, 5 and have been reported to be normocoagulable. 5 While evidence exists that platelet activation secondary to an inflammatory process might offset thrombocytopenia, [5] [6] [7] the receptor-mediated mechanisms by which this occurs are unknown.
Platelet activation occurs when an agonist binds to a receptor, leading to the activation of downstream signaling pathways to result in degranulation, translocation of negatively charged membrane phospholipids to the outer leaflet, and the activation of the glycoprotein (GP) IIbIIIa receptor responsible for binding fibrinogen. Agonists include thrombin, collagen, adenosine diphosphate (ADP), and thromboxane A 2 (TxA 2 ) generated from arachidonic acid (AA). 8 Activated platelets provide a procoagulant surface for large-scale thrombin generation. 8, 9 Thromboelastography (TEG) is a global assessment of hemostasis, 10 and relies on thrombin generation to cleave fibrinogen and activate platelets. 11 The maximum amplitude (MA) is a function of the dynamic interaction between platelets and fibrin(ogen). 10 This modality provides information regarding the patient's maximum hemostatic potential but is nonspecific for platelet activity. 10 Thromboelastographic platelet mapping (TEG-PM) evaluates the individual contributions of thrombin, fibrin, and platelet activity to clot formation. 12 Heparinized blood, in combination with an activator, bypasses thrombin activity, allowing for the assessment of contributions by fibrin and milder platelet agonists, such as ADP and AA. 11, 12 In people, TEG-PM is frequently used to monitor the efficacy of antiplatelet therapy. 13 Thromboelastographic platelet mapping has been reported to be useful for identifying alterations in platelet receptor function during cardiopulmonary bypass, 14 traumatic brain injury, 15 and multisystem trauma. 16 There is a paucity of literature regarding TEG-PM in veterinary medicine. To date, pilot studies have been conducted in dogs 17 and cats, 11 and a small number of studies have used TEG-PM to assess the effects of various medications on platelet function. [18] [19] [20] Only one study has focused on TEG-PM findings in dogs with clinical diseases associated with hypercoagulability, namely hyperadrenocorticism (HAC). 21 The objectives of this study were to investigate possible differences in TEG-PM variables in dogs with complicated B rossi infection compared with those of healthy controls and to determine whether TEG-PM variables correlated with any hematologic and other hemostatic variables. 
| MATERIALS AND METHODS

| Sample collection
At presentation and prior to any treatment (including blood products or intravenous fluids), blood was collected from the jugular vein from each dog using a 21-gauge needle by careful venipuncture with minimum stasis. Blood was collected into serum, sodium citrate, lithium heparin, and ethylenediaminetetraacetic acid (EDTA) Vacutainer tubes (BD Biosciences, Franklin Lakes, NJ, USA), in this order. All tubes were filled, using vacuum assistance to ensure the correct ratio of anticoagulant to blood. The EDTA sample was used to perform the CBC and the PCR/RLB analysis. Standard kaolin-activated TEG was performed on the sodium citrate sample, after which the remainder was centrifuged within 1 hour at 2100g for 8 minutes.
The plasma was stored at −80°C for determination of fibrinogen concentration and antithrombin activity at a later stage. The lithium heparin sample was used to perform the TEG-PM analysis.
| Thromboelastographic platelet mapping analysis
Two thromboelastographic hemostasis analyzers (TEG 5000 Thrombe- 
| Hematology variables
A CBC was performed on an optical-based automated hematology system (ADVIA 2120; Siemens, Munich, Germany) and variables of interest included HCT, platelet count (PLT), plateletcrit (PCT), MPV, mean platelet mass (MPM), and mean platelet component concentration (MPC). Analyses were performed within 30 minutes of sample collection.
| Plasma fibrinogen concentration and antithrombin activity
Plasma fibrinogen concentration a were determined with the Clauss method using an automated coagulometric analyzer (ACL Elite;
Instrumentation Laboratory, Bedford, MA, USA). Plasma antithrombin (AT) activity was assessed using a thrombin-dependent chromogenic substrate assay (Precimat Chromogen; Roche, Basel, Switzerland) on an automated analyzer (Cobas Integra 400 Plus; Roche). A normal pooled control sample, with a presumed activity of 100%, was run with each batch of tests, and the patient AT activity was normalized against the pooled control sample.
| Statistical analysis
Statistical analyses were performed using a commercial software package (SPSS Statistics 24.0 Software; SPSS Inc, Armonk, NY, USA). Data were inspected for normality using the Shapiro-Wilk test and found not to display a normal distribution. Differences between groups were assessed using the Mann-Whitney U test.
Correlations were determined using Spearman's rank correlation coefficient. Gender proportions between groups were compared using the Fisher's exact test. Data are presented as the median and the interquartile range (IQR). In addition, interindividual CVs for the patient and control groups were calculated for the TEG-PM variables by dividing the group standard deviation by the group mean and multiplying this by 100. A P-value of <0.05 was considered statistically significant.
| RESULTS
| Animals
Thirteen dogs were included in the babesiosis group, and five dogs in the control group. There were no significant differences in age between the groups, with the median patient age of 24 months (12-52) and the median control age of 48 months . The male:female ratio was 7:6 for the Babesia-infected dogs and was 3:2 for the controls, with no significant difference between the groups. The following complications were observed either singly or in combination:
IMHA (n = 4), ARDS (n = 2), hepatopathy with cholestasis (n = 3), AKI (n = 2), neurologic signs (n = 4), hypoglycemia (n = 1), and hemoconcentration (n = 3).
| Thromboelastographic platelet mapping analysis
The TEG-PM variables are shown in Table 1 . Median MA Thrombin did not differ significantly between the groups ( Figure 1A) ; however, MA Fibrin was significantly higher in the babesiosis group compared with that of the control group ( Figure 1B) . No significant differences were observed between groups for median MA ADP ( Figure 1C ) and MA AA ( Figure 1D 
| Hematologic variables
Results are shown in Table 1 . The median HCT, PLT, and PCT were significantly decreased, with the MPV and MPM significantly increased in the babesiosis group compared with those of the control group. No significant difference was noted for MPC.
| Plasma fibrinogen concentration and antithrombin activity
Results are shown in Table 1 . The median fibrinogen concentration was significantly increased, and the AT activity was significantly decreased in the babesiosis group compared with the control group.
| Correlation analysis
The The study showed no significant difference for MA Thrombin between the Babesia-infected and healthy control dogs. Maximum amplitude following thrombin generation is the maximum amplitude determined using standard kaolin-activated TEG. Our results are similar to a previous report on uncomplicated babesiosis, using tissue factor-activated TEG. 5 The authors in that study suggested two pos- T A B L E 1 Descriptive statistics for thromboelastographic platelet mapping and hematology variables regarding the Babesia-infected and healthy control dogs the presence of known and surrogate markers of platelet activation, namely increased circulating platelet-monocyte aggregates and increased MPV and MPM. 6, 7 Although MA Thrombin may be affected by PLT, platelet function, and plasma fibrinogen concentration, 10 our study showed a significant correlation with PLT only, but not with any of the markers for platelet activity. HCT is also an important variable to consider because it has been shown that decreased HCT results in more hypercoagulable viscoelastic tracings. 26, 27 However, similar to a previous report, no correlation was seen with HCT in our study cohort. 5 Maximum amplitude due to fibrin alone was significantly increased in the Babesia-infected dogs compared with that of the controls. Rotational thromboelastometry (ROTEM) studies have demonstrated that adequate fibrinogen concentrations are critical for clot formation. [28] [29] [30] Even in the face of severe thrombocytopenia, the maximum clot elasticity (MCE) determined by ROTEM increased exponentially when increasing concentrations of fibrinogen were added. 29 MA Fibrin values than healthy controls at all assessed time points. 21 The HAC study also reported a weakly positive correlation between MA Fibrin and plasma fibrinogen concentration.
Interestingly, the contribution of platelets to clot formation increases in a similar fibrinogen concentration-dependent pattern.
Each platelet bears numerous GP IIbIIIa receptors on its surface, and when activated by thrombin, platelets can bind high numbers of fibrinogen molecules. 34 Thus, each individual platelet could become increasingly engaged with fibrinogen via its GP IIbIIIa receptors as the overall platelet count decreases and the platelet volume increases. 29 Given the inflammatory nature of the disease, which be larger and more hemostatically active, and both platelet size and immaturity are independent determinants of platelet function. 35, 36 The negative correlation between MA Fibrin and PLT is also noteworthy and supports the theory of platelets becoming increasingly engaged with fibrinogen as their numbers decrease, as previously stated. 29 A possible explanation for the negative correlation with HCT is that a defined volume of anticoagulated blood is used for the TEG assay, and erythrocytes act as a functional diluent for plasma, limiting the volume of plasma and plasma coagulation proteins included in the assay. A whole blood sample with a low HCT will consequently allow for more plasma coagulation proteins, specifically fibrinogen, to be included in the assay. 26, 27 Besides hyperfibrinogenemia, other reasons for high MA Fibrin include prior platelet sensitization and AT deficiency. Previous studies in dogs, 17 cats, 11 and horses 18 showed that the MA Fibrin is prone to a high degree of intra-and interindividual variability, with extremely high CVs being obtained in the dog study (>100%). Similarly, the HAC study found a significant overlap between MA Fibrin in the affected dogs and controls. 21 In our study, the interindividual CVs for both the babesiosis and control groups were significantly lower (38.9% and 41.6%, respectively) than previously reported values; and although the sample sizes were small, no overlap was seen between the groups. This, together with a plausible underlying pathomechanism to explain the increased MA Fibrin , suggests that the difference between the groups is due to disease and not biological or analytical variation. Nevertheless, assay analytical precision, as well as biological variation, should be investigated further.
The lack of significant differences between groups for MA ADP and MA AA was unexpected, given that platelet activation has been reported to occur in dogs with canine babesiosis. However, the interindividual variation for both variables was significant, which is similar to previous studies in dogs 17, 37 and cats. 11 There are several potential explanations for the lack of significance, such as the use of suboptimal agonist concentrations. 17 The TEG-PM kit contains heterogeneity seen in infected dogs. 24 However, the study cohort included dogs with the complicated form of the disease, which is associated with an excessive proinflammatory response. 3 Since ADP is released by platelet dense granules during platelet activation to augment the activation response initiated by other agonists, 8 and AA
is an important inflammatory mediator, it would seem unlikely that the function of these receptors was unaltered in this population of dogs. It is also possible that the results varied because of biologic variability, as a great deal of heterogeneity regarding the platelet response to various agonists in dogs exists. [37] [38] [39] The lower HCT could also have affected both the MA AA and MA ADP of the Babesiainfected group; however, no significant correlation with HCT was observed.
Our study had some limitations. Sample sizes were small due to financial constraints, which may have failed to detect significant changes in the MA ADP and MA AA . Due to the nature of sample collection from clinical cases, sampling at a standardized time point in the disease course was not possible. This could also have introduced heterogeneity into the study population. More reliable assays for the determination of platelet activation, such as flow cytometry or aggregometry, were not performed. Thus, it was not possible to show conclusively, using surrogate markers of platelet activation, such as indicated by MPM and MPV, that platelet activation occurred in the dogs of this study. In addition, the TEG-PM assay has not been validated for use in dogs, but several published studies have used this methodology. 11, [17] [18] [19] [20] [21] Lastly, the analytical variation in the variables is presently unknown.
In conclusion, the findings of this study suggest that hyperfibrinogenemia in the presence of large platelets, secondary to either concurrent activation or regeneration, overrides the severe thrombocytopenia associated with canine babesiosis to result in normal thromboelastograms and the absence of clinical bleeding.
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